Advice to Patients
- When taking doxycycline hyclate tablets, importance of drinking sufficient amounts of fluids to reduce the risk of esophageal irritation and ulceration.
- Doxycycline hyclate polymer for subgingival administration is not meant for self-administration; only qualified oral health-care professionals familiar with administration of the subgingival preparation should administer the drug.
- Importance of not using mechanical oral hygiene procedures (i.e., brushing teeth, flossing) for 7 days following administration of the subgingival preparation.
- Importance of avoiding exposure to direct sunlight or UV light while receiving oral or subgingival doxycycline hyclate; importance of notifying clinician and of discontinuing therapy at the first sign of skin erythema.
- Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.
- Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as any concomitant diseases.
- Importance of informing patients of other important precautionary information. (See Cautions.)
Preparations
Doxycycline Hyclate
| Routes | Dosage Forms | Strengths | Brand Names | Manufacturer |
| Oral | Tablets | 20 mg (of doxycycline) |
Periostat® | CollaGenex |
| Tablets, film-coated | 20 mg (of doxycycline)* |
Doxycycline Hyclate Tablets | Teva |
| Subgingival | For liquid, extended-release polymer | 10% w/w (to deliver 42.5 mg [of doxycycline]) |
Atridox® (available in a 2-syringe Atrigel® Delivery System) | CollaGenex |
| * available generically |
AHFS Drug Information. © Copyright, 1959-2008, Selected Revisions June 2006. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.
Remember, keep this and all other medicines out of the reach of children,
never share your medicines with others, and use this medication only for the indication prescribed.